nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—hematologic cancer	0.171	1	CbGaD
Sitagliptin—ABCB1—Lenalidomide—hematologic cancer	0.0317	0.0584	CbGbCtD
Sitagliptin—CYP2C8—Bortezomib—hematologic cancer	0.0287	0.0528	CbGbCtD
Sitagliptin—CYP2C8—Ifosfamide—hematologic cancer	0.022	0.0405	CbGbCtD
Sitagliptin—CYP2C8—Nilotinib—hematologic cancer	0.0191	0.0352	CbGbCtD
Sitagliptin—CYP3A4—Bexarotene—hematologic cancer	0.019	0.035	CbGbCtD
Sitagliptin—ABCB1—Daunorubicin—hematologic cancer	0.0186	0.0342	CbGbCtD
Sitagliptin—ABCB1—Alitretinoin—hematologic cancer	0.0182	0.0335	CbGbCtD
Sitagliptin—CYP3A4—Lomustine—hematologic cancer	0.0177	0.0325	CbGbCtD
Sitagliptin—CYP3A4—Busulfan—hematologic cancer	0.0177	0.0325	CbGbCtD
Sitagliptin—CYP3A4—Thiotepa—hematologic cancer	0.0157	0.029	CbGbCtD
Sitagliptin—ABCB1—Imatinib—hematologic cancer	0.0142	0.0262	CbGbCtD
Sitagliptin—ABCB1—Nilotinib—hematologic cancer	0.0129	0.0238	CbGbCtD
Sitagliptin—ABCB1—Vinorelbine—hematologic cancer	0.0128	0.0236	CbGbCtD
Sitagliptin—CYP3A4—Methoxsalen—hematologic cancer	0.0122	0.0225	CbGbCtD
Sitagliptin—CYP3A4—Bortezomib—hematologic cancer	0.0116	0.0214	CbGbCtD
Sitagliptin—ABCB1—Dasatinib—hematologic cancer	0.0114	0.021	CbGbCtD
Sitagliptin—ABCB1—Mitoxantrone—hematologic cancer	0.0113	0.0208	CbGbCtD
Sitagliptin—CYP3A4—Daunorubicin—hematologic cancer	0.0111	0.0205	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—hematologic cancer	0.0105	0.0194	CbGbCtD
Sitagliptin—ABCB1—Betamethasone—hematologic cancer	0.0101	0.0185	CbGbCtD
Sitagliptin—ABCB1—Gemcitabine—hematologic cancer	0.00997	0.0184	CbGbCtD
Sitagliptin—ABCB1—Prednisolone—hematologic cancer	0.00993	0.0183	CbGbCtD
Sitagliptin—CYP3A4—Cytarabine—hematologic cancer	0.00982	0.0181	CbGbCtD
Sitagliptin—CYP3A4—Teniposide—hematologic cancer	0.00967	0.0178	CbGbCtD
Sitagliptin—ABCB1—Prednisone—hematologic cancer	0.00938	0.0173	CbGbCtD
Sitagliptin—CYP3A4—Ifosfamide—hematologic cancer	0.00893	0.0164	CbGbCtD
Sitagliptin—ABCB1—Irinotecan—hematologic cancer	0.00889	0.0164	CbGbCtD
Sitagliptin—CYP2C8—Dexamethasone—hematologic cancer	0.00865	0.0159	CbGbCtD
Sitagliptin—CYP3A4—Imatinib—hematologic cancer	0.00853	0.0157	CbGbCtD
Sitagliptin—CYP3A4—Ruxolitinib—hematologic cancer	0.00803	0.0148	CbGbCtD
Sitagliptin—ABCB1—Vinblastine—hematologic cancer	0.0079	0.0146	CbGbCtD
Sitagliptin—ABCB1—Vincristine—hematologic cancer	0.00777	0.0143	CbGbCtD
Sitagliptin—CYP3A4—Nilotinib—hematologic cancer	0.00775	0.0143	CbGbCtD
Sitagliptin—CYP3A4—Vinorelbine—hematologic cancer	0.00768	0.0141	CbGbCtD
Sitagliptin—ABCB1—Cisplatin—hematologic cancer	0.00725	0.0133	CbGbCtD
Sitagliptin—ABCB1—Etoposide—hematologic cancer	0.00712	0.0131	CbGbCtD
Sitagliptin—CYP3A4—Triamcinolone—hematologic cancer	0.00703	0.0129	CbGbCtD
Sitagliptin—CYP3A4—Dasatinib—hematologic cancer	0.00685	0.0126	CbGbCtD
Sitagliptin—CYP3A4—Mitoxantrone—hematologic cancer	0.00677	0.0125	CbGbCtD
Sitagliptin—CYP3A4—Betamethasone—hematologic cancer	0.00603	0.0111	CbGbCtD
Sitagliptin—CYP3A4—Prednisolone—hematologic cancer	0.00595	0.011	CbGbCtD
Sitagliptin—ABCB1—Dexamethasone—hematologic cancer	0.00585	0.0108	CbGbCtD
Sitagliptin—CYP3A4—Prednisone—hematologic cancer	0.00562	0.0103	CbGbCtD
Sitagliptin—CYP3A4—Irinotecan—hematologic cancer	0.00533	0.00981	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—hematologic cancer	0.00486	0.00894	CbGbCtD
Sitagliptin—CYP3A4—Vinblastine—hematologic cancer	0.00474	0.00872	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—hematologic cancer	0.0047	0.00866	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—hematologic cancer	0.00466	0.00857	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—hematologic cancer	0.00427	0.00786	CbGbCtD
Sitagliptin—CYP3A4—Dexamethasone—hematologic cancer	0.00351	0.00646	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—hematologic cancer	0.00291	0.00536	CbGbCtD
Sitagliptin—DPP4—hematopoietic system—hematologic cancer	0.000979	0.154	CbGeAlD
Sitagliptin—DPP4—blood—hematologic cancer	0.000648	0.102	CbGeAlD
Sitagliptin—DPP4—bone marrow—hematologic cancer	0.000627	0.0987	CbGeAlD
Sitagliptin—DPP4—lung—hematologic cancer	0.000568	0.0894	CbGeAlD
Sitagliptin—DPP4—testis—hematologic cancer	0.000536	0.0844	CbGeAlD
Sitagliptin—CYP2C8—hematopoietic system—hematologic cancer	0.000471	0.0741	CbGeAlD
Sitagliptin—DPP4—lymph node—hematologic cancer	0.000389	0.0612	CbGeAlD
Sitagliptin—CYP3A4—hematopoietic system—hematologic cancer	0.000319	0.0502	CbGeAlD
Sitagliptin—CYP2C8—blood—hematologic cancer	0.000312	0.0491	CbGeAlD
Sitagliptin—CYP2C8—testis—hematologic cancer	0.000258	0.0406	CbGeAlD
Sitagliptin—ABCB1—hematopoietic system—hematologic cancer	0.000226	0.0355	CbGeAlD
Sitagliptin—CYP3A4—blood—hematologic cancer	0.000211	0.0333	CbGeAlD
Sitagliptin—ABCB1—gonad—hematologic cancer	0.000172	0.027	CbGeAlD
Sitagliptin—ABCB1—blood—hematologic cancer	0.00015	0.0235	CbGeAlD
Sitagliptin—ABCB1—bone marrow—hematologic cancer	0.000145	0.0228	CbGeAlD
Sitagliptin—ABCB1—lung—hematologic cancer	0.000131	0.0206	CbGeAlD
Sitagliptin—ABCB1—testis—hematologic cancer	0.000124	0.0195	CbGeAlD
Sitagliptin—ABCB1—lymph node—hematologic cancer	8.97e-05	0.0141	CbGeAlD
Sitagliptin—Nausea—Ifosfamide—hematologic cancer	3.88e-05	0.000151	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.86e-05	0.000151	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.86e-05	0.000151	CcSEcCtD
Sitagliptin—Myalgia—Prednisone—hematologic cancer	3.85e-05	0.00015	CcSEcCtD
Sitagliptin—Arthralgia—Prednisone—hematologic cancer	3.85e-05	0.00015	CcSEcCtD
Sitagliptin—Feeling abnormal—Triamcinolone—hematologic cancer	3.85e-05	0.00015	CcSEcCtD
Sitagliptin—Diarrhoea—Cisplatin—hematologic cancer	3.85e-05	0.00015	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—hematologic cancer	3.84e-05	0.00015	CcSEcCtD
Sitagliptin—Anxiety—Prednisone—hematologic cancer	3.84e-05	0.00015	CcSEcCtD
Sitagliptin—Vomiting—Gemcitabine—hematologic cancer	3.84e-05	0.00015	CcSEcCtD
Sitagliptin—Insomnia—Betamethasone—hematologic cancer	3.84e-05	0.00015	CcSEcCtD
Sitagliptin—Insomnia—Dexamethasone—hematologic cancer	3.84e-05	0.00015	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.83e-05	0.000149	CcSEcCtD
Sitagliptin—Discomfort—Prednisone—hematologic cancer	3.81e-05	0.000148	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—hematologic cancer	3.81e-05	0.000148	CcSEcCtD
Sitagliptin—Rash—Gemcitabine—hematologic cancer	3.81e-05	0.000148	CcSEcCtD
Sitagliptin—Dermatitis—Gemcitabine—hematologic cancer	3.8e-05	0.000148	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—hematologic cancer	3.8e-05	0.000148	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—hematologic cancer	3.8e-05	0.000148	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—hematologic cancer	3.78e-05	0.000147	CcSEcCtD
Sitagliptin—Headache—Gemcitabine—hematologic cancer	3.78e-05	0.000147	CcSEcCtD
Sitagliptin—Nausea—Vincristine—hematologic cancer	3.78e-05	0.000147	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—hematologic cancer	3.77e-05	0.000147	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisolone—hematologic cancer	3.75e-05	0.000146	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—hematologic cancer	3.74e-05	0.000146	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—hematologic cancer	3.73e-05	0.000146	CcSEcCtD
Sitagliptin—Dyspepsia—Dexamethasone—hematologic cancer	3.73e-05	0.000146	CcSEcCtD
Sitagliptin—Dyspepsia—Betamethasone—hematologic cancer	3.73e-05	0.000146	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—hematologic cancer	3.72e-05	0.000145	CcSEcCtD
Sitagliptin—Urticaria—Triamcinolone—hematologic cancer	3.71e-05	0.000145	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—hematologic cancer	3.71e-05	0.000144	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisone—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Sitagliptin—Decreased appetite—Dexamethasone—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Sitagliptin—Decreased appetite—Betamethasone—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Sitagliptin—Nausea—Mitoxantrone—hematologic cancer	3.68e-05	0.000143	CcSEcCtD
Sitagliptin—Nausea—Irinotecan—hematologic cancer	3.68e-05	0.000143	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—hematologic cancer	3.67e-05	0.000143	CcSEcCtD
Sitagliptin—Infection—Prednisone—hematologic cancer	3.67e-05	0.000143	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Fatigue—Betamethasone—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Fatigue—Dexamethasone—hematologic cancer	3.66e-05	0.000143	CcSEcCtD
Sitagliptin—Pain—Dexamethasone—hematologic cancer	3.63e-05	0.000141	CcSEcCtD
Sitagliptin—Pain—Betamethasone—hematologic cancer	3.63e-05	0.000141	CcSEcCtD
Sitagliptin—Nervous system disorder—Prednisone—hematologic cancer	3.62e-05	0.000141	CcSEcCtD
Sitagliptin—Skin disorder—Prednisone—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Sitagliptin—Nausea—Gemcitabine—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Sitagliptin—Vomiting—Cisplatin—hematologic cancer	3.58e-05	0.000139	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—hematologic cancer	3.56e-05	0.000139	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—hematologic cancer	3.56e-05	0.000139	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—hematologic cancer	3.56e-05	0.000139	CcSEcCtD
Sitagliptin—Rash—Cisplatin—hematologic cancer	3.55e-05	0.000138	CcSEcCtD
Sitagliptin—Dermatitis—Cisplatin—hematologic cancer	3.54e-05	0.000138	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—hematologic cancer	3.54e-05	0.000138	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—hematologic cancer	3.53e-05	0.000137	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—hematologic cancer	3.52e-05	0.000137	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—hematologic cancer	3.51e-05	0.000137	CcSEcCtD
Sitagliptin—Feeling abnormal—Dexamethasone—hematologic cancer	3.5e-05	0.000136	CcSEcCtD
Sitagliptin—Feeling abnormal—Betamethasone—hematologic cancer	3.5e-05	0.000136	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—hematologic cancer	3.49e-05	0.000136	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—hematologic cancer	3.49e-05	0.000136	CcSEcCtD
Sitagliptin—Tension—Epirubicin—hematologic cancer	3.47e-05	0.000135	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.47e-05	0.000135	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.47e-05	0.000135	CcSEcCtD
Sitagliptin—Hypersensitivity—Triamcinolone—hematologic cancer	3.44e-05	0.000134	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—hematologic cancer	3.44e-05	0.000134	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—hematologic cancer	3.42e-05	0.000133	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—hematologic cancer	3.41e-05	0.000133	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—hematologic cancer	3.41e-05	0.000133	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—hematologic cancer	3.41e-05	0.000133	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—hematologic cancer	3.4e-05	0.000133	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—hematologic cancer	3.39e-05	0.000132	CcSEcCtD
Sitagliptin—Urticaria—Dexamethasone—hematologic cancer	3.37e-05	0.000131	CcSEcCtD
Sitagliptin—Urticaria—Betamethasone—hematologic cancer	3.37e-05	0.000131	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.37e-05	0.000131	CcSEcCtD
Sitagliptin—Dizziness—Prednisolone—hematologic cancer	3.36e-05	0.000131	CcSEcCtD
Sitagliptin—Asthenia—Triamcinolone—hematologic cancer	3.35e-05	0.000131	CcSEcCtD
Sitagliptin—Abdominal pain—Dexamethasone—hematologic cancer	3.35e-05	0.000131	CcSEcCtD
Sitagliptin—Abdominal pain—Betamethasone—hematologic cancer	3.35e-05	0.000131	CcSEcCtD
Sitagliptin—Nausea—Cisplatin—hematologic cancer	3.34e-05	0.00013	CcSEcCtD
Sitagliptin—Insomnia—Prednisone—hematologic cancer	3.34e-05	0.00013	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—hematologic cancer	3.34e-05	0.00013	CcSEcCtD
Sitagliptin—Cough—Methotrexate—hematologic cancer	3.3e-05	0.000129	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—hematologic cancer	3.3e-05	0.000128	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—hematologic cancer	3.28e-05	0.000128	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—hematologic cancer	3.28e-05	0.000128	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—hematologic cancer	3.28e-05	0.000128	CcSEcCtD
Sitagliptin—Dyspepsia—Prednisone—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Sitagliptin—Rash—Etoposide—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Sitagliptin—Headache—Etoposide—hematologic cancer	3.23e-05	0.000126	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—hematologic cancer	3.23e-05	0.000126	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—hematologic cancer	3.22e-05	0.000126	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—hematologic cancer	3.22e-05	0.000126	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Sitagliptin—Decreased appetite—Prednisone—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Sitagliptin—Rash—Prednisolone—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Sitagliptin—Dermatitis—Prednisolone—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—hematologic cancer	3.19e-05	0.000124	CcSEcCtD
Sitagliptin—Fatigue—Prednisone—hematologic cancer	3.18e-05	0.000124	CcSEcCtD
Sitagliptin—Headache—Prednisolone—hematologic cancer	3.18e-05	0.000124	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—hematologic cancer	3.18e-05	0.000124	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—hematologic cancer	3.18e-05	0.000124	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—hematologic cancer	3.18e-05	0.000124	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—hematologic cancer	3.17e-05	0.000123	CcSEcCtD
Sitagliptin—Constipation—Prednisone—hematologic cancer	3.16e-05	0.000123	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—hematologic cancer	3.15e-05	0.000123	CcSEcCtD
Sitagliptin—Dizziness—Triamcinolone—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Sitagliptin—Cough—Epirubicin—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Sitagliptin—Infection—Methotrexate—hematologic cancer	3.07e-05	0.00012	CcSEcCtD
Sitagliptin—Nausea—Etoposide—hematologic cancer	3.06e-05	0.000119	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—hematologic cancer	3.06e-05	0.000119	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisone—hematologic cancer	3.04e-05	0.000119	CcSEcCtD
Sitagliptin—Asthenia—Dexamethasone—hematologic cancer	3.04e-05	0.000119	CcSEcCtD
Sitagliptin—Asthenia—Betamethasone—hematologic cancer	3.04e-05	0.000119	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—hematologic cancer	3.04e-05	0.000118	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—hematologic cancer	3.03e-05	0.000118	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Prednisone—hematologic cancer	3.02e-05	0.000118	CcSEcCtD
Sitagliptin—Nausea—Prednisolone—hematologic cancer	3.02e-05	0.000118	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—hematologic cancer	3.01e-05	0.000117	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—hematologic cancer	3.01e-05	0.000117	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—hematologic cancer	3e-05	0.000117	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—hematologic cancer	3e-05	0.000117	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.99e-05	0.000117	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—hematologic cancer	2.98e-05	0.000116	CcSEcCtD
Sitagliptin—Vomiting—Triamcinolone—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—hematologic cancer	2.95e-05	0.000115	CcSEcCtD
Sitagliptin—Rash—Triamcinolone—hematologic cancer	2.95e-05	0.000115	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—hematologic cancer	2.95e-05	0.000115	CcSEcCtD
Sitagliptin—Dermatitis—Triamcinolone—hematologic cancer	2.94e-05	0.000115	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—hematologic cancer	2.94e-05	0.000115	CcSEcCtD
Sitagliptin—Urticaria—Prednisone—hematologic cancer	2.93e-05	0.000114	CcSEcCtD
Sitagliptin—Headache—Triamcinolone—hematologic cancer	2.93e-05	0.000114	CcSEcCtD
Sitagliptin—Abdominal pain—Prednisone—hematologic cancer	2.92e-05	0.000114	CcSEcCtD
Sitagliptin—Diarrhoea—Dexamethasone—hematologic cancer	2.9e-05	0.000113	CcSEcCtD
Sitagliptin—Diarrhoea—Betamethasone—hematologic cancer	2.9e-05	0.000113	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—hematologic cancer	2.89e-05	0.000113	CcSEcCtD
Sitagliptin—Infection—Epirubicin—hematologic cancer	2.87e-05	0.000112	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—hematologic cancer	2.86e-05	0.000111	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—hematologic cancer	2.83e-05	0.00011	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—hematologic cancer	2.83e-05	0.00011	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.81e-05	0.00011	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—hematologic cancer	2.81e-05	0.000109	CcSEcCtD
Sitagliptin—Dizziness—Betamethasone—hematologic cancer	2.8e-05	0.000109	CcSEcCtD
Sitagliptin—Dizziness—Dexamethasone—hematologic cancer	2.8e-05	0.000109	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—hematologic cancer	2.79e-05	0.000109	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—hematologic cancer	2.79e-05	0.000109	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—hematologic cancer	2.79e-05	0.000109	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—hematologic cancer	2.78e-05	0.000108	CcSEcCtD
Sitagliptin—Nausea—Triamcinolone—hematologic cancer	2.78e-05	0.000108	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.77e-05	0.000108	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—hematologic cancer	2.76e-05	0.000107	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—hematologic cancer	2.74e-05	0.000107	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—hematologic cancer	2.73e-05	0.000106	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisone—hematologic cancer	2.72e-05	0.000106	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—hematologic cancer	2.72e-05	0.000106	CcSEcCtD
Sitagliptin—Vomiting—Betamethasone—hematologic cancer	2.7e-05	0.000105	CcSEcCtD
Sitagliptin—Vomiting—Dexamethasone—hematologic cancer	2.7e-05	0.000105	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—hematologic cancer	2.68e-05	0.000105	CcSEcCtD
Sitagliptin—Rash—Dexamethasone—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Rash—Betamethasone—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Dermatitis—Dexamethasone—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Dermatitis—Betamethasone—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—hematologic cancer	2.66e-05	0.000104	CcSEcCtD
Sitagliptin—Headache—Betamethasone—hematologic cancer	2.66e-05	0.000104	CcSEcCtD
Sitagliptin—Headache—Dexamethasone—hematologic cancer	2.66e-05	0.000104	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—hematologic cancer	2.66e-05	0.000104	CcSEcCtD
Sitagliptin—Asthenia—Prednisone—hematologic cancer	2.65e-05	0.000103	CcSEcCtD
Sitagliptin—Pain—Methotrexate—hematologic cancer	2.64e-05	0.000103	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.63e-05	0.000103	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—hematologic cancer	2.62e-05	0.000102	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—hematologic cancer	2.61e-05	0.000102	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—hematologic cancer	2.6e-05	0.000101	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—hematologic cancer	2.57e-05	0.0001	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—hematologic cancer	2.54e-05	9.91e-05	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—hematologic cancer	2.54e-05	9.91e-05	CcSEcCtD
Sitagliptin—Diarrhoea—Prednisone—hematologic cancer	2.53e-05	9.85e-05	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.52e-05	9.84e-05	CcSEcCtD
Sitagliptin—Nausea—Betamethasone—hematologic cancer	2.52e-05	9.82e-05	CcSEcCtD
Sitagliptin—Nausea—Dexamethasone—hematologic cancer	2.52e-05	9.82e-05	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—hematologic cancer	2.51e-05	9.79e-05	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.49e-05	9.72e-05	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—hematologic cancer	2.49e-05	9.71e-05	CcSEcCtD
Sitagliptin—Pain—Epirubicin—hematologic cancer	2.47e-05	9.63e-05	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—hematologic cancer	2.47e-05	9.63e-05	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—hematologic cancer	2.45e-05	9.56e-05	CcSEcCtD
Sitagliptin—Dizziness—Prednisone—hematologic cancer	2.44e-05	9.52e-05	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—hematologic cancer	2.44e-05	9.51e-05	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.44e-05	9.49e-05	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—hematologic cancer	2.42e-05	9.42e-05	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—hematologic cancer	2.38e-05	9.28e-05	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—hematologic cancer	2.38e-05	9.26e-05	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.36e-05	9.21e-05	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—hematologic cancer	2.35e-05	9.17e-05	CcSEcCtD
Sitagliptin—Vomiting—Prednisone—hematologic cancer	2.35e-05	9.15e-05	CcSEcCtD
Sitagliptin—Rash—Prednisone—hematologic cancer	2.33e-05	9.08e-05	CcSEcCtD
Sitagliptin—Dermatitis—Prednisone—hematologic cancer	2.33e-05	9.07e-05	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—hematologic cancer	2.32e-05	9.06e-05	CcSEcCtD
Sitagliptin—Headache—Prednisone—hematologic cancer	2.31e-05	9.02e-05	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.31e-05	8.99e-05	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—hematologic cancer	2.3e-05	8.98e-05	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—hematologic cancer	2.3e-05	8.94e-05	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—hematologic cancer	2.29e-05	8.91e-05	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—hematologic cancer	2.29e-05	8.91e-05	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—hematologic cancer	2.28e-05	8.9e-05	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—hematologic cancer	2.27e-05	8.86e-05	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—hematologic cancer	2.21e-05	8.63e-05	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—hematologic cancer	2.2e-05	8.59e-05	CcSEcCtD
Sitagliptin—Nausea—Prednisone—hematologic cancer	2.19e-05	8.55e-05	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.19e-05	8.52e-05	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—hematologic cancer	2.13e-05	8.3e-05	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—hematologic cancer	2.12e-05	8.28e-05	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—hematologic cancer	2.11e-05	8.24e-05	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—hematologic cancer	2.11e-05	8.23e-05	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—hematologic cancer	2.07e-05	8.08e-05	CcSEcCtD
Sitagliptin—CYP2C8—Metabolism—FTCD—hematologic cancer	2.07e-05	0.000915	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PHYH—hematologic cancer	2.07e-05	0.000915	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	2.07e-05	0.000913	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.05e-05	0.000905	CbGpPWpGaD
Sitagliptin—Dizziness—Methotrexate—hematologic cancer	2.04e-05	7.96e-05	CcSEcCtD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.02e-05	0.000894	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.02e-05	0.000894	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.02e-05	0.000894	CbGpPWpGaD
Sitagliptin—Diarrhoea—Epirubicin—hematologic cancer	1.98e-05	7.7e-05	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—hematologic cancer	1.97e-05	7.68e-05	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.97e-05	0.000869	CbGpPWpGaD
Sitagliptin—Vomiting—Methotrexate—hematologic cancer	1.96e-05	7.65e-05	CcSEcCtD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.95e-05	0.000862	CbGpPWpGaD
Sitagliptin—Rash—Methotrexate—hematologic cancer	1.95e-05	7.59e-05	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—hematologic cancer	1.94e-05	7.58e-05	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.94e-05	0.000856	CbGpPWpGaD
Sitagliptin—Headache—Methotrexate—hematologic cancer	1.93e-05	7.54e-05	CcSEcCtD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.93e-05	0.000853	CbGpPWpGaD
Sitagliptin—Asthenia—Doxorubicin—hematologic cancer	1.92e-05	7.47e-05	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—hematologic cancer	1.91e-05	7.45e-05	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.9e-05	0.000842	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SMPD3—hematologic cancer	1.89e-05	0.000837	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.89e-05	0.000835	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.85e-05	0.000817	CbGpPWpGaD
Sitagliptin—Vomiting—Epirubicin—hematologic cancer	1.84e-05	7.16e-05	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—hematologic cancer	1.83e-05	7.15e-05	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—hematologic cancer	1.83e-05	7.13e-05	CcSEcCtD
Sitagliptin—Rash—Epirubicin—hematologic cancer	1.82e-05	7.1e-05	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—hematologic cancer	1.82e-05	7.09e-05	CcSEcCtD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.82e-05	0.000805	CbGpPWpGaD
Sitagliptin—Headache—Epirubicin—hematologic cancer	1.81e-05	7.05e-05	CcSEcCtD
Sitagliptin—ABCB1—Metabolism—FTCD—hematologic cancer	1.8e-05	0.000797	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GMPS—hematologic cancer	1.8e-05	0.000797	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PHYH—hematologic cancer	1.8e-05	0.000797	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.79e-05	0.000791	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.78e-05	0.000788	CbGpPWpGaD
Sitagliptin—Dizziness—Doxorubicin—hematologic cancer	1.77e-05	6.89e-05	CcSEcCtD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.76e-05	0.00078	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.72e-05	0.00076	CbGpPWpGaD
Sitagliptin—Nausea—Epirubicin—hematologic cancer	1.72e-05	6.69e-05	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—hematologic cancer	1.7e-05	6.62e-05	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—hematologic cancer	1.69e-05	6.57e-05	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—hematologic cancer	1.68e-05	6.56e-05	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—hematologic cancer	1.67e-05	6.53e-05	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.66e-05	0.000733	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ASNS—hematologic cancer	1.65e-05	0.000731	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—DCK—hematologic cancer	1.65e-05	0.000731	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—B3GAT1—hematologic cancer	1.65e-05	0.000731	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SMPD3—hematologic cancer	1.65e-05	0.000729	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.64e-05	0.000726	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.62e-05	0.000715	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.6e-05	0.000706	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.59e-05	0.000704	CbGpPWpGaD
Sitagliptin—Nausea—Doxorubicin—hematologic cancer	1.59e-05	6.19e-05	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.57e-05	0.000696	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.57e-05	0.000693	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HDC—hematologic cancer	1.57e-05	0.000693	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.56e-05	0.00069	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.53e-05	0.000678	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.52e-05	0.000674	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.52e-05	0.000674	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.46e-05	0.000646	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.46e-05	0.000646	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.45e-05	0.000641	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ASNS—hematologic cancer	1.44e-05	0.000637	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.44e-05	0.000637	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—DCK—hematologic cancer	1.44e-05	0.000637	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CDA—hematologic cancer	1.43e-05	0.000634	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.43e-05	0.000632	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.4e-05	0.000621	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PC—hematologic cancer	1.38e-05	0.00061	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.38e-05	0.00061	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.37e-05	0.000608	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.37e-05	0.000605	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HDC—hematologic cancer	1.37e-05	0.000604	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.34e-05	0.000592	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GBA—hematologic cancer	1.33e-05	0.000589	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC35B2—hematologic cancer	1.33e-05	0.000589	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.33e-05	0.000589	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.33e-05	0.000588	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.32e-05	0.000583	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.31e-05	0.000581	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.31e-05	0.000577	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.3e-05	0.000576	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CDA—hematologic cancer	1.25e-05	0.000552	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.24e-05	0.000549	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTAP—hematologic cancer	1.22e-05	0.000539	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PC—hematologic cancer	1.2e-05	0.000532	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.18e-05	0.000521	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.16e-05	0.000514	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GBA—hematologic cancer	1.16e-05	0.000513	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.16e-05	0.000513	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.16e-05	0.000513	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PHYH—hematologic cancer	1.11e-05	0.000491	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FTCD—hematologic cancer	1.11e-05	0.000491	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GMPS—hematologic cancer	1.11e-05	0.000491	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FHL2—hematologic cancer	1.09e-05	0.00048	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AGRN—hematologic cancer	1.07e-05	0.000471	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTAP—hematologic cancer	1.06e-05	0.00047	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.06e-05	0.000469	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.04e-05	0.00046	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.02e-05	0.000449	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.01e-05	0.000448	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.01e-05	0.000447	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH2—hematologic cancer	1.01e-05	0.000447	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMMR—hematologic cancer	1.01e-05	0.000447	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	9.79e-06	0.000433	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	9.77e-06	0.000432	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.74e-06	0.000431	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	9.56e-06	0.000423	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.53e-06	0.000421	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ARNTL—hematologic cancer	9.5e-06	0.00042	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FHL2—hematologic cancer	9.47e-06	0.000419	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	9.32e-06	0.000412	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AGRN—hematologic cancer	9.28e-06	0.00041	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACP5—hematologic cancer	9.24e-06	0.000409	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA9—hematologic cancer	9.24e-06	0.000409	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOR2—hematologic cancer	9.12e-06	0.000403	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	9.06e-06	0.000401	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.88e-06	0.000392	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ASNS—hematologic cancer	8.88e-06	0.000392	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—DCK—hematologic cancer	8.88e-06	0.000392	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.83e-06	0.00039	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMMR—hematologic cancer	8.8e-06	0.000389	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH2—hematologic cancer	8.8e-06	0.000389	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH1—hematologic cancer	8.69e-06	0.000384	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TXN—hematologic cancer	8.59e-06	0.00038	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTO1—hematologic cancer	8.59e-06	0.00038	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCC3—hematologic cancer	8.59e-06	0.00038	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HDC—hematologic cancer	8.41e-06	0.000372	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SPHK1—hematologic cancer	8.41e-06	0.000372	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	8.35e-06	0.000369	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ARNTL—hematologic cancer	8.27e-06	0.000366	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.12e-06	0.000359	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.1e-06	0.000358	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—UGT1A1—hematologic cancer	8.08e-06	0.000357	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA9—hematologic cancer	8.05e-06	0.000356	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACP5—hematologic cancer	8.05e-06	0.000356	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOR2—hematologic cancer	7.94e-06	0.000351	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.86e-06	0.000347	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.86e-06	0.000347	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CDA—hematologic cancer	7.7e-06	0.00034	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALOX5—hematologic cancer	7.66e-06	0.000339	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH1—hematologic cancer	7.57e-06	0.000335	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	7.56e-06	0.000334	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.5e-06	0.000332	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TXN—hematologic cancer	7.48e-06	0.000331	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ABCC3—hematologic cancer	7.48e-06	0.000331	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTO1—hematologic cancer	7.48e-06	0.000331	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NUP98—hematologic cancer	7.41e-06	0.000328	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PC—hematologic cancer	7.41e-06	0.000328	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SPHK1—hematologic cancer	7.32e-06	0.000324	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ADCY7—hematologic cancer	7.2e-06	0.000318	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOA3—hematologic cancer	7.2e-06	0.000318	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GBA—hematologic cancer	7.15e-06	0.000316	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.15e-06	0.000316	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NUP214—hematologic cancer	7.15e-06	0.000316	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.07e-06	0.000313	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.04e-06	0.000311	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCG2—hematologic cancer	7e-06	0.00031	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTR—hematologic cancer	7e-06	0.00031	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.89e-06	0.000305	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO2—hematologic cancer	6.87e-06	0.000304	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.84e-06	0.000303	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CRABP1—hematologic cancer	6.84e-06	0.000303	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALOX5—hematologic cancer	6.67e-06	0.000295	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.67e-06	0.000295	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.66e-06	0.000294	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.56e-06	0.00029	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTAP—hematologic cancer	6.54e-06	0.000289	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SDC1—hematologic cancer	6.51e-06	0.000288	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NUP98—hematologic cancer	6.46e-06	0.000286	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ADCY7—hematologic cancer	6.27e-06	0.000277	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOA3—hematologic cancer	6.27e-06	0.000277	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NUP214—hematologic cancer	6.23e-06	0.000275	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.22e-06	0.000275	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.14e-06	0.000271	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTR—hematologic cancer	6.1e-06	0.00027	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ABCG2—hematologic cancer	6.1e-06	0.00027	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO2—hematologic cancer	5.98e-06	0.000265	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.87e-06	0.00026	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FHL2—hematologic cancer	5.83e-06	0.000258	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—hematologic cancer	5.8e-06	0.000257	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AGRN—hematologic cancer	5.72e-06	0.000253	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SDC1—hematologic cancer	5.67e-06	0.000251	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.63e-06	0.000249	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NQO1—hematologic cancer	5.54e-06	0.000245	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CD44—hematologic cancer	5.54e-06	0.000245	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.43e-06	0.00024	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH2—hematologic cancer	5.42e-06	0.00024	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMMR—hematologic cancer	5.42e-06	0.00024	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.42e-06	0.00024	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYCS—hematologic cancer	5.24e-06	0.000232	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.2e-06	0.00023	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.1e-06	0.000225	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.09e-06	0.000225	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA9—hematologic cancer	4.96e-06	0.000219	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACP5—hematologic cancer	4.96e-06	0.000219	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.89e-06	0.000216	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CD44—hematologic cancer	4.82e-06	0.000213	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NQO1—hematologic cancer	4.82e-06	0.000213	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.68e-06	0.000207	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH1—hematologic cancer	4.66e-06	0.000206	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.62e-06	0.000204	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.61e-06	0.000204	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TXN—hematologic cancer	4.61e-06	0.000204	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.61e-06	0.000204	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYCS—hematologic cancer	4.56e-06	0.000202	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.53e-06	0.0002	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.51e-06	0.000199	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.47e-06	0.000197	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.37e-06	0.000193	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.33e-06	0.000192	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.24e-06	0.000188	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.24e-06	0.000188	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.22e-06	0.000186	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.22e-06	0.000186	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.11e-06	0.000182	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—hematologic cancer	4.02e-06	0.000178	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.98e-06	0.000176	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.86e-06	0.000171	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.86e-06	0.000171	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.84e-06	0.00017	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTR—hematologic cancer	3.76e-06	0.000166	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.76e-06	0.000166	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.75e-06	0.000166	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOR1—hematologic cancer	3.7e-06	0.000163	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—hematologic cancer	3.7e-06	0.000163	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO2—hematologic cancer	3.69e-06	0.000163	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.57e-06	0.000158	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SDC1—hematologic cancer	3.49e-06	0.000154	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.3e-06	0.000146	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—hematologic cancer	3.27e-06	0.000144	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.15e-06	0.000139	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CD44—hematologic cancer	2.97e-06	0.000131	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.97e-06	0.000131	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.92e-06	0.000129	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.81e-06	0.000124	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.79e-06	0.000124	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.77e-06	0.000122	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.74e-06	0.000121	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—hematologic cancer	2.73e-06	0.000121	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.61e-06	0.000116	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CREBBP—hematologic cancer	2.54e-06	0.000113	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.48e-06	0.00011	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.41e-06	0.000107	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.41e-06	0.000107	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—hematologic cancer	2.38e-06	0.000105	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.35e-06	0.000104	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.28e-06	0.000101	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.28e-06	0.000101	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.28e-06	0.000101	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.1e-06	9.3e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—hematologic cancer	2.09e-06	9.22e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.01e-06	8.9e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—EP300—hematologic cancer	1.99e-06	8.8e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—hematologic cancer	1.82e-06	8.03e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—EP300—hematologic cancer	1.73e-06	7.66e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.69e-06	7.48e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.57e-06	6.93e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.49e-06	6.57e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.47e-06	6.51e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—hematologic cancer	1.47e-06	6.49e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.4e-06	6.21e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.3e-06	5.73e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.28e-06	5.67e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—hematologic cancer	1.2e-06	5.31e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—hematologic cancer	1.12e-06	4.95e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—EP300—hematologic cancer	1.07e-06	4.72e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—hematologic cancer	1.05e-06	4.63e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.9e-07	3.49e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—hematologic cancer	6.45e-07	2.85e-05	CbGpPWpGaD
